Home/Pipeline/B-HB Portfolio Expansion

B-HB Portfolio Expansion

Diabetic Ketoacidosis (DKA) Monitoring

Commercial & ExpansionActive

Key Facts

Indication
Diabetic Ketoacidosis (DKA) Monitoring
Phase
Commercial & Expansion
Status
Active
Company

About EKF Diagnostics

EKF Diagnostics Holdings plc is a mission-driven, AIM-listed company focused on improving global healthcare through accessible, rapid diagnostic solutions and high-quality life science components. The company has established a mature, dual-pillar business model combining proprietary POC device sales with a robust contract manufacturing and reagent supply division for the biotech and pharma industries. Its strategy is built on geographic expansion, digital connectivity via its EKF Link platform, and continuous portfolio diversification across clinical and non-clinical markets, supported by a resilient global supply chain.

View full company profile